Please note that the agenda may be subject to minor changes due to unforeseen circumstances.

Opening Activities

08:00    Registration Opens  |  Partnering Sessions, and Networking in the Exhibition Area

 

08:40    Welcome | Opening Remarks 
Moderator: Nina Rawal, Venture Capital Investor & Board Member 

Session 1 | The European & Nordic Life Science Landscape

08:45    Global Shifts, Local Consequences – Implications for Swedish & Danish Life Science
Pieter van der Meijden, Managing Director Healthcare Investment Banking, DNB Carnegie Back Bay

 

09:05    European Life Science in Transition – A Decisive Moment to Tackle Global Challenges
Sofia Wallström, Board member, EFPIA – European Federation of Pharmaceutical Industries and Associations

 

09:20    MedTech and EU Regulations – Past, Present, and Beyond
Åsa Betten, CEO, TÜV NORD Scandinavia MNB

 

09:40    Danish Life Science – A Strategic Part of the European Life Science Ecosystem
Katrina Feilberg Schouenborg, Vice President, Health and Life Science, Danish Chamber of Commerce

 

09:55    Sweden Incorporated: Innovation, Resilience, and the Road Ahead
Jessica Martinsson, CEO, SwedenBIO

 

10:10    European Competitiveness Through Strategic Multiplication
Stefan Jovinge, President of Research, Education, Development and Innovation, Skåne University Hospital

10:25    Coffee, Partnering Sessions, and Networking in the Exhibition Area

 

10:55    Quantum Life Sciences and Applications
Ebba Carbonnier, CEO, QuNorth

Session 2 | Talent & Workforce – Building the Future Life Science Ecosystem

11:15    Where Science Meets Digital: Building the Next Generation Workforce in Danish and Swedish Life Sciences
Niels Buch Leander, Executive Vice President, Chief Digital Officer, PharmaRelations

 

11:35    Academic-Industry Collaboration for Skills Development
Andreas Inghammar, Deputy Dean, Lund University School of Economics and Management

 

11:55    Attracting and Retaining International STEM Talent – a Shared Effort
Marie-Louise Lövgren, Business Developer, Region Skåne
Sofia Hindgård, Regional Development Strategist, Region Skåne

 

12:15    Partner Pitch: You Don’t Have a Talent Problem – You Have a Decision Problem
Lucian Jon, Operations Director, NES Fircroft

12:20   Lunch, Partnering Sessions, and Networking in the Exhibition Area

Session 3 | Innovation & Commercialization – From Research to Market

13:00    BII’s Perspective on Bringing Science to Life
Trine Bartholdy, Chief Business Officer, BioInnovation Institute

 

13:15    From Innovation to International Impact
Fredrik Olsson, CEO, Genovis

 

13:25    Turning Discovery into Therapy: Building a First-in-Class Cancer Immunotherapy
Cristiana Pires, CEO & Co-founder, Asgard Therapeutics

 

13:35    Insurance in Life Science: From Risk to Resilience
Johan Berg, Head of Large & Complex, Gallagher

 

13:50    Bridging Discovery and Clinical Impact: The Role of CRO Expertise in Modern Drug Development
Karin Enell Smith, PhD, Head of CRO Services, Svar Life Science

 

14:05    Better Samples – Better Science: Introducing a Novel Cryo Storage Technology for Biobanks
Hans-Christoph Paul, Owner, HCP Life Science Innovation
Gesine Paul-Visse, Consultant Neurologist, Professor, Lund University & Skåne University Hospital

 

14:20    Partner Pitch: Next Generation Air Solutions for Pharma: Speed. Trust & Sustainability from Lab to Patient
Simon W Caplan, Sponsorship Manager, FlyPharma

14:25    Coffee, Partnering Sessions, and Networking in the Exhibition Area

Session 4 | Funding & Investment – Financing the Nordic Life Science Growth

14:55    Building Biotech Companies in the Nordics
Søren Møller, Managing Partner, Seed Investments, Novo Holdings

 

15:10    Breakthrough T1D: Accelerating Innovation Through Strategic Research Partnerships in Europe
Hilda Ahnstedt, Program Officer, European Research, Breakthrough T1D

 

15:25    Panel Discussion  |  Building World-Class Companies That Attract Global Investors
Emanuel Stihl, Managing Partner FSG Fund I, Fåhraeus Startup And Growth
Hilda Ahnstedt
, Program Officer, European Research, Breakthrough T1D
Markus Neuding, Owner, Sedermera Corporate Finance
Søren Møller, Managing Partner, Seed Investments, Novo Holdings

Session 5 | Concluding Activities

15:50    Looking Ahead: Cross-Border Collaboration & Next Steps
Short, interactive discussion, summarizing key takeaways.
Sarah Lidé, Deputy CEO, Medicon Village Innovation

 

16:05    Science After Work – Networking Reception in the Exhibition Area
A great opportunity to unwind and continue the discussions in a relaxed setting, while enjoying drinks & refreshments.
The reception also features a short interview with Pieter van der Meijden, Managing Director Healthcare Investment Banking, DNB Carnegie Back Bay.